205 related articles for article (PubMed ID: 18175224)
1. The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: a novel oncogenic pathway.
Lam-Himlin DM; Daniels JA; Gayyed MF; Dong J; Maitra A; Pan D; Montgomery EA; Anders RA
Int J Gastrointest Cancer; 2006; 37(4):103-9. PubMed ID: 18175224
[TBL] [Abstract][Full Text] [Related]
2. LKB1 inhibits the proliferation of gastric cancer cells by suppressing the nuclear translocation of Yap and β-catenin.
Ma LG; Bian SB; Cui JX; Xi HQ; Zhang KC; Qin HZ; Zhu XM; Chen L
Int J Mol Med; 2016 Apr; 37(4):1039-48. PubMed ID: 26936013
[TBL] [Abstract][Full Text] [Related]
3. Expression of tumoral FOXP3 in gastric adenocarcinoma is associated with favorable clinicopathological variables and related with Hippo pathway.
Suh JH; Won KY; Kim GY; Bae GE; Lim SJ; Sung JY; Park YK; Kim YW; Lee J
Int J Clin Exp Pathol; 2015; 8(11):14608-18. PubMed ID: 26823784
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions.
Montgomery E; Mamelak AJ; Gibson M; Maitra A; Sheikh S; Amr SS; Yang S; Brock M; Forastiere A; Zhang S; Murphy KM; Berg KD
Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):24-30. PubMed ID: 16540726
[TBL] [Abstract][Full Text] [Related]
5. Nuclear accumulation of beta-catenin is a common and early event during neoplastic progression of Barrett esophagus.
Bian YS; Osterheld MC; Bosman FT; Fontolliet C; Benhattar J
Am J Clin Pathol; 2000 Oct; 114(4):583-90. PubMed ID: 11026105
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
7. Expression of insulin-like growth factor II mRNA-binding protein 3 in human esophageal adenocarcinoma and its precursor lesions.
Feng W; Zhou Z; Peters JH; Khoury T; Zhai Q; Wei Q; Truong CD; Song SW; Tan D
Arch Pathol Lab Med; 2011 Aug; 135(8):1024-31. PubMed ID: 21809994
[TBL] [Abstract][Full Text] [Related]
8. Hippo pathway effector Yap is an ovarian cancer oncogene.
Hall CA; Wang R; Miao J; Oliva E; Shen X; Wheeler T; Hilsenbeck SG; Orsulic S; Goode S
Cancer Res; 2010 Nov; 70(21):8517-25. PubMed ID: 20947521
[TBL] [Abstract][Full Text] [Related]
9. YAP is a candidate oncogene for esophageal squamous cell carcinoma.
Muramatsu T; Imoto I; Matsui T; Kozaki K; Haruki S; Sudol M; Shimada Y; Tsuda H; Kawano T; Inazawa J
Carcinogenesis; 2011 Mar; 32(3):389-98. PubMed ID: 21112960
[TBL] [Abstract][Full Text] [Related]
10. Ski/SnoN expression in the sequence metaplasia-dysplasia-adenocarcinoma of Barrett's esophagus.
Villanacci V; Bellone G; Battaglia E; Rossi E; Carbone A; Prati A; Verna C; Niola P; Morelli A; Grassini M; Bassotti G
Hum Pathol; 2008 Mar; 39(3):403-9. PubMed ID: 18261624
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral vector-mediated siRNA knockdown of the YAP gene inhibits growth and induces apoptosis in the SGC7901 gastric cancer cell line.
Zhou Z; Zhu JS; Xu ZP; Zhang Q
Mol Med Rep; 2011; 4(6):1075-82. PubMed ID: 21805037
[TBL] [Abstract][Full Text] [Related]
12. Promyelocytic leukemia protein enhances apoptosis of gastric cancer cells through Yes-associated protein.
Xu Z; Chen J; Shao L; Ma W; Xu D
Tumour Biol; 2015 Sep; 36(10):8047-54. PubMed ID: 25971581
[TBL] [Abstract][Full Text] [Related]
13. Nuclear localization of Toll-like receptor 5 in Barrett's esophagus and esophageal adenocarcinoma is associated with metastatic behavior.
Helminen O; Huhta H; Leppänen J; Kauppila JH; Takala H; Lehenkari PP; Saarnio J; Karttunen TJ
Virchows Arch; 2016 Oct; 469(4):465-70. PubMed ID: 27392931
[TBL] [Abstract][Full Text] [Related]
14. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D
Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359
[TBL] [Abstract][Full Text] [Related]
15. Expression analysis of Barrett's esophagus-associated high-grade dysplasia in laser capture microdissected archival tissue.
Sabo E; Meitner PA; Tavares R; Corless CL; Lauwers GY; Moss SF; Resnick MB
Clin Cancer Res; 2008 Oct; 14(20):6440-8. PubMed ID: 18927283
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor is highly expressed in precancerous lesions and esophageal adenocarcinoma with significant sex difference.
Zhou Z; Xia Y; Bandla S; Zakharov V; Wu S; Peters J; Godfrey TE; Sun J
Hum Pathol; 2014 Aug; 45(8):1744-51. PubMed ID: 24951052
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic Drosha Is Aberrant in Precancerous Lesions of Gastric Carcinoma and Its Loss Predicts Worse Outcome for Gastric Cancer Patients.
Zhang H; Hou Y; Xu L; Zeng Z; Wen S; Du YE; Sun K; Yin J; Lang L; Tang X; Liu M
Dig Dis Sci; 2016 Apr; 61(4):1080-90. PubMed ID: 26694172
[TBL] [Abstract][Full Text] [Related]
18. Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus.
Glickman JN; Blount PL; Sanchez CA; Cowan DS; Wongsurawat VJ; Reid BJ; Odze RD
Hum Pathol; 2006 Oct; 37(10):1304-15. PubMed ID: 16949933
[TBL] [Abstract][Full Text] [Related]
19. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins.
Chatelain D; Fléjou JF
Virchows Arch; 2003 Jan; 442(1):18-24. PubMed ID: 12536310
[TBL] [Abstract][Full Text] [Related]
20. Expression of Yes-associated protein in gastric adenocarcinoma and inhibitory effects of its knockdown on gastric cancer cell proliferation and metastasis.
Zhang J; Xu ZP; Yang YC; Zhu JS; Zhou Z; Chen WX
Int J Immunopathol Pharmacol; 2012; 25(3):583-90. PubMed ID: 23058008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
